My 72 yr old mother in law was diagnosed with Stage IV NSCLC in Feb. She had 4 rounds of Alimta/Carboplatin with Avastin. She responded so well (no more lung tumor growth and normal liver function) that her oncologist recommended not having her last 2 treatments and starting Tarceva (although she does not have the EGFR mutation).
Tarceva failed miserably and after 6 weeks or so on it, her liver function is much worse than when she was diagnosed. She has come off Tarceva, but it seems we've figured this out too late. She's very weak now.
Just wondering if anyone has had this experience and how was the response to the 2nd round of Alimta. Is it worth putting her body through it. I've heard that subsequent rounds of chemo are less and less effective.
Should we encourage her to fight or will this just be more misery for her?
Edited June 27, 2010 at 5:31 pm